Fate Therapeutics

In News

FATE Stock Jumps 6% As FDA Greenlights Moving Cell Therapy To Clinical Trials - stocktwits.com

stocktwits.com - Sep 06, 2026

Fate Therapeutics to Participate in Fireside Chat at the 2026 Annual Cantor Global Healthcare Conference - Yahoo Finance

Yahoo Finance - Sep 03, 2026

Fate Therapeutics: RECLAIM-LN Underway, Additional Clinical Updates Ahead (NASDAQ:FATE) - Seeking Alpha

Seeking Alpha - Sep 02, 2026

A lupus trial that could support approval is on Fate Therapeutics’ agenda Sept. 9. - Stock Titan

Stock Titan - Sep 03, 2026

Fate Therapeutics begins Phase II trial of FT819 for lupus nephritis - Clinical Trials Arena

Clinical Trials Arena - Aug 17, 2026

Fate Therapeutics Gets FDA Clearance for FT839 Autoimmune CAR-T Therapy - The Clinical Trial Vanguard

The Clinical Trial Vanguard - Jul 10, 2026

BlackRock Inc. Makes New Investment in Fate Therapeutics, Inc. $FATE - MarketBeat

MarketBeat - Sep 03, 2026

Fate’s off-the-shelf CAR-T therapy shows early promise in treatment-resistant autoimmune disease - Fierce Biotech

Fierce Biotech - Jul 09, 2026

Fate Therapeutics Wins FDA IND Clearance for FT839, a Dual-CAR T-Cell Therapy for Autoimmune Disease - BioPharm International

BioPharm International - Jul 09, 2026

Fate Therapeutics (FATE) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance

Yahoo Finance - Aug 13, 2026

Fate Therapeutics Initiates Potentially Registrational RECLAIM-LN Clinical Trial of FT819 for the Treatment of Lupus Nephritis - GlobeNewswire

GlobeNewswire - Aug 14, 2026

Fate Therapeutics Reports Second Quarter 2026 Financial Results and Business Updates - Yahoo Finance

Yahoo Finance - Aug 13, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment